IRIS
CENCI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.783
EU - Europa 1.681
AS - Asia 1.548
SA - Sud America 271
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 36
OC - Oceania 1
Totale 5.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.668
RU - Federazione Russa 995
SG - Singapore 597
CN - Cina 510
IT - Italia 281
BR - Brasile 221
HK - Hong Kong 159
VN - Vietnam 142
SE - Svezia 80
FR - Francia 75
DE - Germania 74
CA - Canada 56
GB - Regno Unito 48
FI - Finlandia 38
IN - India 33
BD - Bangladesh 27
MX - Messico 24
PL - Polonia 20
ES - Italia 18
AR - Argentina 16
TR - Turchia 14
JP - Giappone 13
ZA - Sudafrica 13
AT - Austria 12
EC - Ecuador 12
NL - Olanda 12
AE - Emirati Arabi Uniti 8
LT - Lituania 7
MY - Malesia 7
ID - Indonesia 6
JM - Giamaica 6
UZ - Uzbekistan 6
CO - Colombia 5
CR - Costa Rica 5
IQ - Iraq 5
PE - Perù 5
PK - Pakistan 5
KE - Kenya 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
UY - Uruguay 4
BB - Barbados 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
PY - Paraguay 3
RO - Romania 3
SN - Senegal 3
VE - Venezuela 3
BZ - Belize 2
CH - Svizzera 2
CL - Cile 2
CU - Cuba 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GP - Guadalupe 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
QA - Qatar 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 5.320
Salva come PNG Salva come JPEG
Città #
Singapore 331
Ashburn 280
San Jose 230
Moscow 210
Hong Kong 157
Dallas 129
Shanghai 91
Milan 71
Council Bluffs 67
Hefei 62
Beijing 59
New York 58
Los Angeles 52
Lauterbourg 50
Ho Chi Minh City 48
Phoenix 42
Santa Clara 35
Hanoi 34
Boardman 26
Lawrence 26
Princeton 26
Montreal 23
São Paulo 23
Helsinki 22
Orem 20
Chennai 19
Munich 19
Warsaw 18
Chicago 17
Atlanta 15
Boston 15
Denver 15
Manchester 14
Miano 14
Brooklyn 13
London 13
Nuremberg 13
Stockholm 13
Frankfurt am Main 12
Rome 12
The Dalles 12
Johannesburg 11
Mexico City 11
Tokyo 11
Washington 11
Da Nang 9
Falkenstein 9
San Francisco 9
Tianjin 9
Florence 8
Guangzhou 8
Rio de Janeiro 8
Seattle 8
Turku 8
Ankara 7
Brasília 7
Buffalo 7
Lappeenranta 7
Belo Horizonte 6
Bologna 6
Charlotte 6
Dubai 6
Guayaquil 6
Houston 6
Poplar 6
Monza 5
North Bergen 5
Porto Alegre 5
Rho 5
Shenzhen 5
Tashkent 5
Vancouver 5
Verona 5
Wuxi 5
Amsterdam 4
Bogotá 4
Brescia 4
Dhaka 4
Genoa 4
Haiphong 4
Kansas City 4
Kingston 4
Lima 4
Montevideo 4
Naples 4
Newark 4
Ottawa 4
Quito 4
The Bronx 4
Toronto 4
Turin 4
Vienna 4
Bridgetown 3
Buenos Aires 3
Calgary 3
Cesano Boscone 3
Changsha 3
Charleston 3
Chengdu 3
Curitiba 3
Totale 2.737
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 176
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 156
A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver 148
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation 140
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 128
HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases 126
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR Metabolomics. 123
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 122
Autophagy in Plasma Cell Ontogeny and Malignancy 120
MHC Class II Transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity 120
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 116
Iron increases the susceptibility of multiple myeloma cells to bortezomib 114
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 112
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors 109
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells 107
Autophagy in plasma cell pathophysiology 106
Plasma cells require autophagy for sustainable immunoglobulin production 106
A New Fluorogenic Peptide Determines Proteasome Activity in Single Cells 106
Autophagy, a new determinant of plasma cell differentiation and antibody responses 104
Autophagy and longevity: Evolutionary hints from hyper-longevous mammals 102
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells 99
Autophagy in Plasma Cells 95
FAM46C-dependent tuning of endoplasmic reticulum capacity in Multiple Myeloma 95
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation 91
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator 91
B lymphocytes inhibit human osteoclastogenesis by secretion of TGF beta 89
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 89
Editorial: Advances in Plasma Cells in Health and Disease 88
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 87
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE 82
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease 79
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator 78
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling 78
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel 75
Autophagy in the regulation of protein secretion in immune cells 72
The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis 72
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 71
IRON CONTRIBUTES TO BORTEZOMIB SENSITIVITY IN MULTIPLE MYELOMA CELLS 70
Hip fracture in nursing homes: An Italian study on prevalence latency, risk factors, and impact on mobility 67
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 67
PROGRESSIVELY IMPAIRED PROTEASOMAL CAPACITY DURING TERMINAL PLASMA CELL DIFFERENTIATION 66
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma 65
Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo 63
Ex vivo gene expression of osteoblasts in maxillary sinus grafting 63
Short-term reproducibility of proximal femur bone mineral density in the elderly 63
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis 61
Toll-like receptor 9 stimulation can induce I kappa B zeta expression and IgM secretion in chronic lymphocytic leukemia cells 61
Recent advances and future directions in targeting the secretory apparatus in multiple myeloma 61
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition 58
M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss 57
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma 57
Managing and exploiting stress in the antibody factory 57
Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines 53
The Proteasome in Terminal Plasma Cell Differentiation 53
Therapeutic Efficacy of Hematopoietic Stem Cell Gene Therapy for Hurler Type 1 Mucopolysaccharidosis 53
Metabolomics of B to Plasma Cell Differentiation 52
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency 51
Proteostenosis and Plasma Cell Pathophysiology 51
The problem of arteriovenous malformations of the spinal cord in the elderly: Case report of an octogenarian 50
PROTEOSTASIS AS A SIGNALING DEVICE AND THERAPEUTIC TARGET 50
T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms 45
Proteotoxic stress and cell lifespan control 44
The role of autophagy in plasma cell ontogenesis 43
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation 43
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma 29
A wholesale approach to disarm multiple myeloma 13
null 1
Totale 5.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 6 1 3 3 0 3 0 0 0
2022/2023150 58 30 6 0 1 15 3 5 6 15 10 1
2023/2024317 38 27 56 28 16 34 9 35 0 7 12 55
2024/2025937 81 15 42 42 39 87 118 93 154 103 66 97
2025/20263.205 227 206 131 406 367 90 331 244 890 152 60 101
2026/2027793 101 166 177 349 0 0 0 0 0 0 0 0
Totale 5.439